Ali Akamkam

Simon Dang Van^1,2,3, 

Dorothée Brunet^1,2,3, 

Ali Akamkam^1,2,3, 

Benoit Decante^1,2, 

Julien Guihaire^1,2,3 

¹Laboratory of Preclinical Research, Department of Research and Innovation, Groupe Hospitalier Paris Saint Joseph, 

²Inserm UMR S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, 

³Department of Cardiac Surgery, Marie Lannelongue Hospital 

Ali Akamkam^1,2,3, 

Vincenzo Palermo⁴, 

Tiphaine Legrand⁵, 

Guillaume Fadel^2,3,6, 

Benoît Decante^2,3, 

Simon Dang Van^2,3,7, 

Jean-Noel Andarelli⁴, 

Valérie Furlan⁵, 

Julien Guihaire^1,2,3,8 

¹Department of Cardiovascular Surgery, Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, 

²Laboratory of Preclinical Research, Department of Research and Innovation, Groupe Hospitalier Paris Saint Joseph, 

³Inserm UMR S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, 

⁴Department of Cardiology, Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, 

⁵Department of Pharmacology and Toxicology, AP-HP. University of Paris-Saclay, 

⁶Department of Thoracic Surgery, Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, 

⁷Department of Cardiovascular Surgery, University Hospital of Angers, 

⁸, University of Paris Saclay